CYSTECTOMIA ES KEMOTERAPIA A HOLYAGRAK KEZELESEBEN

J. Kondas, G. Konder, E. Szentgyorgyi, I. Bodrogi, L. Engloner

Research output: Article

Abstract

Cytotoxic chemotherapy, - 11 neoadjuvant and 17 adjuvant (4 mixed form) treatment, - was used in 24 cases in addition to radical cystectomy on patients with invasive urothelial-cell bladder cancer. Remission rate after the neoadjuvant treatment was 4/12, 3 complete remission among them. One patient died due to operative complication and one owing to the chemotherapy. During the 17 months mean follow up two patients died because of cancer generalisation. For the treatment of T(3b)-T4 urothelial bladder tumors with vascular or lymphogenic invasion cytotoxic chemotherapy is suggested in addition to the radical cystectomy. Patient survival was better after radical cystectomy with chemotherapy than survival after surgical therapy alone.

Translated title of the contributionCystectomy and cytotoxic chemotherapy in the treatment of bladder cancer
Original languageHungarian
Pages (from-to)209-216
Number of pages8
JournalMagyar Urologia
Volume8
Issue number3
Publication statusPublished - jan. 1 1996

Keywords

  • Adjuvant chemotherapy
  • Invasive bladder cancer
  • Neoadjuvant chemotherapy
  • Radical cystectomy
  • Transitional cell carcinoma

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'CYSTECTOMIA ES KEMOTERAPIA A HOLYAGRAK KEZELESEBEN'. Together they form a unique fingerprint.

  • Cite this

    Kondas, J., Konder, G., Szentgyorgyi, E., Bodrogi, I., & Engloner, L. (1996). CYSTECTOMIA ES KEMOTERAPIA A HOLYAGRAK KEZELESEBEN. Magyar Urologia, 8(3), 209-216.